Publications by authors named "C Gaillez"

Claim this Profile
R
Relationship of radiographic progression status to low disease activity in patients with psoriatic arthritis receiving secukinumab treatment for two years.
Philip J Mease, Laura C Coates, Corine Gaillez, Alexis Shew, Weibin Bao

Rheumatology (Oxford)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study.
Gurjit S Kaeley, Georg Schett, Philip G Conaghan, Dennis McGonagle, Frank Behrens, Corine Gaillez

Rheumatology (Oxford)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension.
Maria Antonietta D'Agostino, Philippe Carron, Corine Gaillez, Philip G Conaghan, Esperanza Naredo

Semin Arthritis Rheum· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2-5 and MAXIMISE studies.
Renaud Felten, Laura Widawski, Lionel Spielmann, Corine Gaillez, Weibin Bao

RMD Open· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study.
Laura C Coates, Philip J Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, Corine Gaillez

RMD Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis